Acutus Medical, Inc. (AFIB)
OTCMKTS
· Delayed Price · Currency is USD
0.0470
0.00 (0.00%)
Mar 28, 2025, 4:00 PM EST
Acutus Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
Net Income | -9.55 | -81.66 | -39.62 | -117.68 | -101.98 | Upgrade
|
Depreciation & Amortization | 1.03 | 0.87 | 1.21 | 6.89 | 3.9 | Upgrade
|
Other Amortization | 0.93 | 0.57 | 0.85 | 1.4 | 0.77 | Upgrade
|
Loss (Gain) From Sale of Assets | -10.81 | -9.08 | -79.47 | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 12.03 | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | -0.03 | -1.43 | -0.02 | 1.28 | 0.48 | Upgrade
|
Stock-Based Compensation | 0.46 | 3.03 | 3.4 | 13.75 | 12.1 | Upgrade
|
Other Operating Activities | 4.8 | 66.93 | 73.39 | -1.54 | 5.65 | Upgrade
|
Change in Accounts Receivable | -4.05 | -1.07 | -0.46 | -1.47 | -1.9 | Upgrade
|
Change in Inventory | 2.49 | -2.48 | -0.07 | -3.87 | -3.89 | Upgrade
|
Change in Accounts Payable | -1.49 | 0.29 | -0.2 | -0.87 | 2.28 | Upgrade
|
Change in Other Net Operating Assets | -0.96 | 4.19 | -1.88 | 2.43 | -2.59 | Upgrade
|
Operating Cash Flow | -31.66 | -63.12 | -88.92 | -99.68 | -85.17 | Upgrade
|
Capital Expenditures | -0.11 | -0.22 | -0.23 | -9.97 | -11.23 | Upgrade
|
Divestitures | 18.67 | 17 | 70 | - | - | Upgrade
|
Investment in Securities | 3.25 | 42.99 | 38.73 | 29.04 | -52.6 | Upgrade
|
Other Investing Activities | 0.34 | -1.21 | -3.75 | - | - | Upgrade
|
Investing Cash Flow | 22.15 | 58.56 | 104.75 | 19.07 | -63.82 | Upgrade
|
Long-Term Debt Issued | - | - | 34.83 | - | - | Upgrade
|
Long-Term Debt Repaid | -2.63 | - | -44.55 | - | - | Upgrade
|
Net Debt Issued (Repaid) | -2.63 | - | -9.73 | - | - | Upgrade
|
Issuance of Common Stock | - | 0.03 | 0.28 | 83.81 | 166.93 | Upgrade
|
Repurchase of Common Stock | - | - | -0.11 | - | - | Upgrade
|
Other Financing Activities | -0.27 | -2.69 | -2.06 | -4.24 | -2.5 | Upgrade
|
Financing Cash Flow | -2.89 | -2.66 | -11.62 | 79.57 | 164.43 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.22 | 2.08 | 2.91 | -0.12 | 0.34 | Upgrade
|
Net Cash Flow | -12.18 | -5.15 | 7.13 | -1.16 | 15.78 | Upgrade
|
Free Cash Flow | -31.77 | -63.34 | -89.15 | -109.66 | -96.39 | Upgrade
|
Free Cash Flow Margin | -157.62% | -884.10% | -2941.11% | -635.20% | -1138.87% | Upgrade
|
Free Cash Flow Per Share | -1.07 | -2.18 | -2.40 | -3.83 | -8.45 | Upgrade
|
Cash Interest Paid | 4.54 | 5.01 | 4.23 | 4.26 | 4.68 | Upgrade
|
Levered Free Cash Flow | -6.78 | 8.17 | -34.29 | -71.95 | -74.68 | Upgrade
|
Unlevered Free Cash Flow | -4.11 | 11.14 | -31.92 | -69.81 | -72.01 | Upgrade
|
Change in Net Working Capital | -0.41 | -20.38 | 20.47 | 8.06 | 19.77 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.